Theravance Biopharma (TBPH) EBITDA (2013 - 2026)
Theravance Biopharma (TBPH) posted EBITDA of -$7.91 million for Q2 2026, compared with -$2.32 million a year earlier.
Powered by 
Analysis
Theravance Biopharma (TBPH) EBITDA (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Theravance Biopharma was -$2.65 million; for FY2025, it was -$1.98 million.
- In prior years, Theravance Biopharma's EBITDA was -$45.24 million in FY2024, -$54.03 million in FY2023, -$88.24 million in FY2022 and -$252.98 million in FY2021.
- Quarterly EBITDA has run from a low of -$55.92 million in Q4 2021 to a high of $20.41 million in Q4 2025 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$9.1 million (Q1 2026), $20.41 million (Q4 2025) and -$6.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -7.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.91 Mn |
| Mar 31, 2026 | -9.10 Mn |
| Dec 31, 2025 | 20.41 Mn |
| Sep 30, 2025 | -6.05 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -14.02 Mn |
| Dec 31, 2024 | -8.78 Mn |
| Sep 30, 2024 | -10.41 Mn |
| Jun 30, 2024 | -15.28 Mn |
| Mar 31, 2024 | -10.78 Mn |
| Dec 31, 2023 | -5.85 Mn |
| Sep 30, 2023 | -8.33 Mn |
| Jun 30, 2023 | -15.57 Mn |
| Mar 31, 2023 | -24.29 Mn |
| Dec 31, 2022 | -16.77 Mn |
| Sep 30, 2022 | -8.04 Mn |
| Jun 30, 2022 | -25.91 Mn |
| Mar 31, 2022 | -37.18 Mn |
| Dec 31, 2021 | -54.89 Mn |
| Sep 30, 2021 | -50.98 Mn |
API Access
Theravance Biopharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();